查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1426120

全球免疫分析市場評估：依產品、技術、分析物、應用、最終用戶、地區、機會、預測（2017-2031）

Immunoassay Market Assessment, By Product, By Technique, By Specimen, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 223 Pages | 商品交期: 3-5個工作天內

價格

全球免疫分析市場規模預計將從 2023 年的 341.1 億美元增至 2031 年的 496.3 億美元，2024-2031 年預測期間複合年增長率為 4.8%。Masu。 全球免疫分析市場的成長受到多種因素的推動，例如慢性病和傳染病的流行、老年人口的增加、生物技術行業的技術進步和創新、醫療保健支出的增加以及政府舉措。

由於全球心血管疾病、糖尿病和癌症等慢性疾病的盛行率不斷上升，全球免疫分析市場呈現強勁成長。 久坐的生活方式、不健康的飲食以及飲酒和吸煙的增加是慢性病患者數量不斷增加的主要危險因素。 傳染病的增加也加速了市場的成長。 這是因為免疫測定在多種疾病的檢測和監測中發揮重要作用。 人口老化加劇是傳染病和慢性病最常見的危險因子之一。 免疫測定是從篩檢和定期監測的角度準確、快速診斷這些疾病的重要工具。 為了提供優質的醫療保健和升級醫療設施，政府鼓勵私人公司投資於研發（R＆D），以獲得更有效和高效的免疫分析平台和技術。 此外，免疫分析在醫院、診所和生技公司等各醫療部門的廣泛使用也顯著增加了對免疫分析診斷的需求。

慢性病和傳染病流行

慢性病和傳染病的流行正在推動全球免疫分析市場的發展。 隨著這些疾病的盛行率持續上升，用於診斷和監測各種疾病的免疫測定的需求不斷增加。 這促進了創新產品的開發，並增加了基於免疫分析的現場護理 (POC) 和快速檢測的採用。 免疫測定用於診斷各種傳染病，如水痘、登革熱、伊波拉出血熱、流感和肝炎。 它是檢測臨床樣本中是否有特定病毒、病毒抗原和抗體的寶貴工具。 衛生專業人員只有透過早期診斷和準確檢測疾病及其病原體才能有效解決此問題，以指導適當的治療。

例如，rRT-PCR 在 SARS-CoV-2 感染過程中發揮了重要作用，預計免疫檢測在未來的大流行中將更加必要。 隨著疾病負擔的增加，對免疫分析的需求也在增加，推動了全球免疫分析市場的成長。

技術進步

近年來，生技領域的技術進步令人矚目，免疫分析市場的技術創新也不斷進步。 透過提高免疫測定特異性的新技術和方法，這些進步旨在提高測試的特性和潛力，最終實現更好的疾病診斷和治療。 例如，2022 年在 Biosensors 上發表的一篇題為 "奈米技術和生物技術的進展" 的論文描述了一種被稱為 "奈米□（BD1）" 的獨特□的獨特□特性。 這些奈米□具有不同的催化機制，可以設計為建構模擬□的免疫測定法的標籤，並提高檢測靈敏度和選擇性。 奈米□表現出高可調的催化活性、易於製備、穩定性高且成本低廉。 由於這些因素，奈米□比天然□更受歡迎，因為它們可以克服天然□的缺點。 這些在提高免疫測定靈敏度方面的進步進一步推動了全球免疫測定市場的成長。

本報告針對全球免疫分析市場進行研究與分析，提供市場規模與預測、市場動態、主要參與者現況及前景等。

目錄

第 1 章研究方法

第 2 章專案範圍與定義

第 3 章全球免疫分析市場未來展望

第 4 章執行摘要

第 5 章全球免疫分析市場展望（2017-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 按產品
    • 試劑/試劑盒
    • 分析器
    • 軟體服務
  • 按技術
    • ELISA
    • 快速測試
    • 酵素相關免疫斑點
    • 蛋白質印跡法
    • 免疫PCR
    • 其他技術
  • 按樣本
    • 血
    • 唾液
    • 尿液
    • 其他
  • 依用途
    • 腫瘤
    • 心臟病
    • 治療藥物監測
    • 傳染病
    • 內分泌
    • 自體免疫疾病
    • 其他
  • 按最終用戶
    • 醫院
    • 臨床研究所
    • 製藥公司、生技公司
    • 血庫
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 南美洲
    • 亞太地區
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 6 章全球免疫分析市場展望：按地區劃分（2017-2031 年）

  • 北美
    • 市場規模與預測
    • 按產品
    • 按技術
    • 按樣本
    • 依用途
    • 按最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美洲
    • 巴西
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 7 章市場地圖（2023 年）

  • 按產品
  • 按技術
  • 按樣本
  • 依用途
  • 按最終用戶
  • 按地區

第 8 章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 9 章市場動態

  • 生長促進因素
  • 生長抑制因素（問題、限制因素）

第 10 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新技術

第 11 章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家公司進入市場）
  • 專利分析（如果適用）

第 12 章價格分析

第 13 章案例研究

第 14 章主要公司展望

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Thermo Fisher Scientific Company
  • QuidelOrtho Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Beckman Coulter, Inc.

第 15 章策略建議

第 16 章關於我們公司，免責聲明

Product Code: MX10983

Global immunoassay market is projected to witness a CAGR of 4.8% during the forecast period 2024-2031, growing from USD 34.11 billion in 2023 to USD 49.63 billion in 2031. Growth in the global immunoassay market is driven by various factors such as the rising prevalence of chronic diseases and infectious diseases, the growing elderly population, technological advancements and innovations in the biotech industry, increased healthcare expenditure, and government initiatives.

The global immunoassay market is undergoing robust growth due to the growing prevalence of chronic diseases around the world, such as cardiovascular diseases, diabetes, and cancer. A sedentary lifestyle, unhealthy diet, and increasing alcohol and tobacco consumption are the main risk factors that are contributing to the growing number of patients with chronic diseases. An increasing number of infectious diseases are also accelerating the growth of the global immunoassay market, as immunoassay has an important role in detecting and monitoring several diseases. Increase in elderly population is one of the most common risk factors for chronic as well as infectious diseases, as elderly people are more prone to these diseases. Immunoassay is an important tool for accurate and fast diagnosis of these diseases in terms of screening and regular monitoring. To deliver high-quality medical care and upgrade healthcare facilities, governments are encouraging private companies to invest more in research and development (R&D) of more effective and efficient immunoassay platforms and technologies. Moreover, wide applications of immunoassay in different healthcare sectors like hospitals, clinics, biotechnology companies are significantly increasing the demand for immunoassay diagnostics.

Increasing Prevalence of Chronic and Infectious Diseases

The increasing prevalence of chronic and infectious diseases drives the global immunoassay market. As the incidence of these diseases continues to rise, there is a growing demand for immunoassays to diagnose and monitor various conditions. This has led to the development of innovative products and the adoption of immunoassay-based point-of-care (POC) testing and rapid testing. Immunoassay is used to diagnose a variety of infectious diseases, including chickenpox, dengue, ebola, influenza, and hepatitis. It is a valuable tool for detecting the presence of specific viruses, viral antigens, or antibodies in clinical specimens. Healthcare professionals can only effectively address this issue by guiding the appropriate treatment through early diagnosis and accurate detection of the disease and its causing agent.

For instance, rRT-PCR played a crucial role during SARS-CoV-2 infection, and it is expected that immunoassay will further be required in future pandemics. With growing burden of these diseases, demand for immunoassay is also increasing, facilitating growth of global immunoassay market.

Technological Advancements

Over the past few years, there has been a surge of favorable technological advancements in the biotechnology sector, which, in turn, has also led to innovation in the immunoassay market. With novel techniques and methods to improve the immunoassay's specificity, these advancements aim to improve the characteristics and potential of the test, which may ultimately lead to better disease diagnosis and treatment. For instance, an article titled "The advancement in nanotechnology and biotechnology", published in Biosensors journals in the year 2022, described the invention of a new type of nanomaterial with intrinsic enzyme-like characteristics known as "nanozymes[BD1]". These nanozymes have different catalytic mechanisms, mimic enzymes, and can be designed as labels in constructing immunoassays to improve detection sensitivity and selectivity. Nanozymes exhibit high catalytic activity with tunability, easy preparation, high stability, and low cost. Due to these factors, nanozymes are gaining significant traction over natural enzymes, as they also eliminate the latter's defects. These advancements to improve immunoassays sensitivity further propel the growth of global immunoassay market.

Government Initiatives

Immunoassays are valuable tools used for various purpose such as disease diagnosis, research and development in biopharmaceuticals, including vaccines and gene and cell therapy, and drug monitoring. Due to its wide applications, governments around the globe have initiated several policies and programs, emphasizing the importance of technological advancements and improvements in immunoassay technique quality. Governments are investing billions of dollars in R&D to bring innovation in modern immunoassay diagnostic techniques.

For instance, in September 2023, the National Institute of Justice (NIJ) announced funding of $1.9 million to support forensic science research under its Public Labs R&E program. This funding helps NIJ to improve the examination and analysis of the most efficient, reliable, accurate, and cost-effective methods of analysis in the public forensic labs, including the development of a method for product and biological tissue analysis and assess cross-reactivity of immunoassay.

Increasing Volume of ELISA

Enzyme-linked immunosorbent assay (ELISA) is one of the most widely used immunoassay methods against HCoVs (Human Coronaviruses) and other viruses. Due to its ease of use with simple procedure, high throughput, rapid, high sensitivity, and good specificity, ELISA is gaining popularity among the major players. ELISA is a safe, eco-friendly, and cost-effective essay diagnostic procedure. Due to this, many major players are launching innovative techniques in ELISA to improve their product portfolios.

For instance, in October 2023, QIAGEN launched QuantiFERON-EBV RUO. This was designed to support research and development in EBV infection (Ebola Virus) and EBV-related malignancies. It uses QuantiFERON technology, along with ELISA detection system, to enable the researcher to study the immune response in the virus, which will further assist in improving the medical treatment against these viruses. These new launches and innovations in immunoassays are driving the global immunoassay market.

Growing Applications of Immunoassay

Immunoassay tests have a vast area of applications, including medical diagnostics, environmental testing, and food safety. Immunoassay tests are used for diagnosing infectious diseases, such as HIV, hepatitis, and tuberculosis, screening and monitoring for drugs abuse, and identifying and measuring allergens in food and environmental samples. They also gain traction as they provide rapid and accurate diagnostic results for point-of-care testing in different healthcare settings. Due to this, many market players are launching novel products in immunoassays to enhance their diagnostic products portfolio.

For instance, in May 2023, Beckman Coulter, a leader in clinical diagnostics, launched DxI 9000 Access Immunoassay Analyzer. This product has the potential to run up to 215 tests per hour. This technology has zero daily maintenance and will enable the healthcare professionals to improve throughput rates with great precision.

Future Market Scenario (2024-2031F)

Global immunoassay market is expected to grow tremendously in the coming years due to multiple factors. One of the primary drivers include an increasing prevalence of chronic and infectious diseases and a growing geriatric population. This will be further supported by rapid technological advancements and the integration of AI, resulting in accurate diagnosis and improved accuracy, especially for community-level surveillance. Moreover, government initiatives, policies, and programs are expected to enhance screening, which, in turn, will create a favorable market outlook. In line with this, increasing investments by public and private companies for research and development in their respective markets and collaborative ventures involving diagnostic device manufacturers and research institutions have spurred innovation leading to further growth of the global immunoassay market.

Key Players Landscape and Outlook

In the immunoassay industry, several public and private organizations are actively establishing strategic partnerships and distribution agreements to empower and strengthen each other's resources, gain insights regarding new markets and advanced technologies, and expand their businesses across the globe. Many big players are undergoing mergers and acquisitions, and partnerships to enhance and strengthen their product portfolios. For instance, on July 2023, Beckman Coulter Diagnostics, which is a leader in clinical diagnostics, and Fujirebio, a pioneer in neurological markers and a leader in manufacturing In Vitro Diagnostic (IVD), announced a new strategic partnership to combine their respective immunoassay strengths to support clinical trials, therapeutic development, reimbursement, and routine clinical adoption in neurodegenerative diseases.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Future Outlook of Global Immunoassay Market

4. Executive Summary

5. Global Immunoassay Market Outlook, 2017-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. Value
    • 5.1.2. Volume
  • 5.2. By Product
    • 5.2.1. Reagents & Kits
    • 5.2.2. Analyzers
    • 5.2.3. Software & Services
  • 5.3. By Technique
    • 5.3.1. Enzyme-Linked Immunosorbent Assays
    • 5.3.2. Rapid Tests
    • 5.3.3. Enzyme-Linked Immunospot
    • 5.3.4. Western Blotting
    • 5.3.5. Immuno-PCR
    • 5.3.6. Other Techniques
  • 5.4. By Specimen
    • 5.4.1. Blood
    • 5.4.2. Saliva
    • 5.4.3. Urine
    • 5.4.4. Others
  • 5.5. By Application
    • 5.5.1. Oncology
    • 5.5.2. Cardiology
    • 5.5.3. Therapeutic Drug Monitoring
    • 5.5.4. Infectious Diseases
    • 5.5.5. Endocrinology
    • 5.5.6. Autoimmune Diseases
    • 5.5.7. Others
  • 5.6. By End-user
    • 5.6.1. Hospitals
    • 5.6.2. Clinical Laboratories
    • 5.6.3. Pharmaceutical and Biotech Companies
    • 5.6.4. Blood Banks
    • 5.6.5. Others
  • 5.7. By Region
    • 5.7.1. North America
    • 5.7.2. Europe
    • 5.7.3. South America
    • 5.7.4. Asia-Pacific
    • 5.7.5. Middle East and Africa
  • 5.8. By Company Market Share (%), 2023

6. Global Immunoassay Market Outlook, By Region, 2017-2031F

  • 6.1. North America*
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. Value
      • 6.1.1.2. Volume
    • 6.1.2. By Product
      • 6.1.2.1. Reagents & Kits
      • 6.1.2.2. Analyzers
      • 6.1.2.3. Software & Services
    • 6.1.3. By Technique
      • 6.1.3.1. Enzyme-Linked Immunosorbent Assays
      • 6.1.3.2. Rapid Tests
      • 6.1.3.3. Enzyme-Linked Immunospot
      • 6.1.3.4. Western Blotting
      • 6.1.3.5. Immuno-PCR
      • 6.1.3.6. Others
    • 6.1.4. By Specimen
      • 6.1.4.1. Blood
      • 6.1.4.2. Saliva
      • 6.1.4.3. Urine
      • 6.1.4.4. Others
    • 6.1.5. By Application
      • 6.1.5.1. Oncology
      • 6.1.5.2. Cardiology
      • 6.1.5.3. Therapeutic Drug Monitoring
      • 6.1.5.4. Infectious Diseases
      • 6.1.5.5. Endocrinology
      • 6.1.5.6. Autoimmune Diseases
      • 6.1.5.7. Others
    • 6.1.6. By End-user
      • 6.1.6.1. Hospitals
      • 6.1.6.2. Clinical Laboratories
      • 6.1.6.3. Pharmaceutical and Biotech Companies
      • 6.1.6.4. Blood Banks
      • 6.1.6.5. Others
    • 6.1.7. United States*
      • 6.1.7.1. Market Size & Forecast
      • 6.1.7.1.1. Value
      • 6.1.7.1.2. Volume
      • 6.1.7.2. By Product
      • 6.1.7.2.1. Reagents & Kits
      • 6.1.7.2.2. Analyzers
      • 6.1.7.2.3. Software & Services
      • 6.1.7.3. By Technique
      • 6.1.7.3.1. Enzyme-Linked Immunosorbent Assays
      • 6.1.7.3.2. Rapid Tests
      • 6.1.7.3.3. Enzyme-Linked Immunospot
      • 6.1.7.3.4. Western Blotting
      • 6.1.7.3.5. Immuno-PCR
      • 6.1.7.3.6. Others
      • 6.1.7.4. By Specimen
      • 6.1.7.4.1. Blood
      • 6.1.7.4.2. Saliva
      • 6.1.7.4.3. Urine
      • 6.1.7.4.4. Others
      • 6.1.7.5. By Application
      • 6.1.7.5.1. Oncology
      • 6.1.7.5.2. Cardiology
      • 6.1.7.5.3. Therapeutic Drug Monitoring
      • 6.1.7.5.4. Infectious Diseases
      • 6.1.7.5.5. Endocrinology
      • 6.1.7.5.6. Autoimmune Diseases
      • 6.1.7.5.7. Others
      • 6.1.7.6. By End-user
      • 6.1.7.6.1. Hospitals
      • 6.1.7.6.2. Clinical Laboratories
      • 6.1.7.6.3. Pharmaceutical and Biotech Companies
      • 6.1.7.6.4. Blood Banks
      • 6.1.7.6.5. Others
    • 6.1.8. Canada
    • 6.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Product
  • 7.2. By Technique
  • 7.3. By Specimen
  • 7.4. By Application
  • 7.5. By End-user
  • 7.6. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Abbott Laboratories
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. F. Hoffmann-La Roche AG
  • 14.3. Siemens Healthineers
  • 14.4. Becton, Dickinson and Company
  • 14.5. BioMerieux SA
  • 14.6. Thermo Fisher Scientific Company
  • 14.7. QuidelOrtho Corporation
  • 14.8. Bio-Rad Laboratories, Inc.
  • 14.9. Merck KGaA
  • 14.10. Beckman Coulter, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 5. Global Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 6. Global Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Immunoassay Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 11. North America Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 12. North America Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 13. North America Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 14. North America Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Immunoassay Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 19. United States Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 20. United States Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 21. United States Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 22. United States Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 26. Canada Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 27. Canada Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 28. Canada Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 29. Canada Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 33. Mexico Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 34. Mexico Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 35. Mexico Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 36. Mexico Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 40. Europe Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 41. Europe Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 42. Europe Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 43. Europe Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Immunoassay Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. Germany Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 49. Germany Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 50. Germany Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 51. Germany Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 55. France Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 56. France Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 57. France Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 58. France Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 59. France Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 62. Italy Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 63. Italy Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 64. Italy Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 65. Italy Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 69. United Kingdom Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 70. United Kingdom Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 71. United Kingdom Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 72. United Kingdom Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 76. Russia Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 77. Russia Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 78. Russia Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 79. Russia Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 80. Russia Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 81. Netherlands Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 83. Netherlands Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 84. Netherlands Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 85. Netherlands Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 86. Netherlands Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 87. Netherlands Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 88. Spain Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Spain Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 91. Spain Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 92. Spain Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 93. Spain Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 94. Spain Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 95. Turkey Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 97. Turkey Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 98. Turkey Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 99. Turkey Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 100. Turkey Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 101. Turkey Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 102. Poland Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 104. Poland Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 105. Poland Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 106. Poland Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 107. Poland Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 108. Poland Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 109. South America Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 111. South America Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 112. South America Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 113. South America Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 114. South America Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 115. South America Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 116. South America Immunoassay Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 119. Brazil Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 120. Brazil Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 121. Brazil Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 122. Brazil Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 123. Brazil Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 124. Argentina Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 126. Argentina Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 127. Argentina Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 128. Argentina Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 129. Argentina Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 130. Argentina Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 131. Asia-Pacific Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 133. Asia-Pacific Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 134. Asia-Pacific Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 135. Asia-Pacific Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 136. Asia-Pacific Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 137. Asia- Pacific Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 138. Asia-Pacific Immunoassay Market Share (%), By Country, 2017-2031F
  • Figure 139. India Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 141. India Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 142. India Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 143. India Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 144. India Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 145. India Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 146. China Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 148. China Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 149. China Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 150. China Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 151. China Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 152. China Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 153. Japan Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 155. Japan Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 156. Japan Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 157. Japan Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 158. Japan Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 159. Japan Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 160. Australia Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 162. Australia Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 163. Australia Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 164. Australia Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 165. Australia Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 166. Australia Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 167. Vietnam Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 169. Vietnam Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 170. Vietnam Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 171. Vietnam Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 172. Vietnam Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 173. Vietnam Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 174. South Korea Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 176. South Korea Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 177. South Korea Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 178. South Korea Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 179. South Korea Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 180. South Korea Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 181. Indonesia Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. Indonesia Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 184. Indonesia Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 185. Indonesia Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 186. Indonesia Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 187. Indonesia Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 188. Philippines Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 190. Philippines Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 191. Philippines Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 192. Philippines Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 193. Philippines Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 194. Philippines Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 195. Middle East & Africa Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 197. Middle East & Africa Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 198. Middle East & Africa Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 199. Middle East & Africa Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 200. Middle East & Africa Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 201. Middle East & Africa Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 202. Middle East & Africa Immunoassay Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 205. Saudi Arabia Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 206. Saudi Arabia Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 207. Saudi Arabia Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 208. Saudi Arabia Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 209. Saudi Arabia Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 210. UAE Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 212. UAE Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 213. UAE Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 214. UAE Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 215. UAE Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 216. UAE Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 217. South Africa Immunoassay Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Immunoassay Market, By Volume, In Million Units, 2017-2031F
  • Figure 219. South Africa Immunoassay Market Share (%), By Product, 2017-2031F
  • Figure 220. South Africa Immunoassay Market Share (%), By Technique, 2017-2031F
  • Figure 221. South Africa Immunoassay Market Share (%), By Specimen, 2017-2031F
  • Figure 222. South Africa Immunoassay Market Share (%), By Application, 2017-2031F
  • Figure 223. South Africa Immunoassay Market Share (%), By End-user, 2017-2031F
  • Figure 224. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Specimen Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023